Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis

  1. Arroyo, R.
  2. Bury, D.P.
  3. Guo, J.D.
  4. Margolin, D.H.
  5. Melanson, M.
  6. Daizadeh, N.
  7. Cella, D.
Journal:
Multiple Sclerosis Journal

ISSN: 1477-0970,  1352-4585

Year of publication: 2020

Volume: 26

Issue: 8

Pages: 955-963

Type: Article

DOI: 10.1177/1352458519849796 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus